The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer

The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in... Ann Surg Oncol (2017) 24:2563–2569 DOI 10.1245/s10434-017-5903-6 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer 1,5 2,5 3,5 3,5 Faina Nakhlis, MD , Meredith M. Regan, ScD , Laura E. Warren, MD , Jennifer R. Bellon, MD , 5 1,5 1,5 1,5 Judith Hirshfield-Bartek, RN , Margaret M. Duggan, MD , Laura S. Dominici, MD , Mehra Golshan, MD , 4,5 4,5 5 5 Heather A. Jacene, MD , Eren D. Yeh, MD , Erin E. Mullaney, RN , and Beth Overmoyer, MD 1 2 Department of Surgery, Brigham and Women’s Hospital, Boston, MA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, Brigham and Women’s 4 5 Hospital, Boston, MA; Department of Radiology, Brigham and Women’s Hospital, Boston, MA; Inflammatory Breast Cancer Program of Dana-Farber Cancer Institute, Boston, MA ABSTRACT 0.07–0.41, p\ 0.0001, multivariate) and improved OS Background. Inflammatory breast cancer (IBC) is a rare (HR 0.26, 95% CI 0.11–0.65, p \ 0.01, univariate). In and aggressive disease treated with multimodality therapy: patients with pCR, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer

Loading next page...
 
/lp/springer_journal/the-impact-of-residual-disease-after-preoperative-systemic-therapy-on-cgV9qRa8Zo
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-017-5903-6
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2017) 24:2563–2569 DOI 10.1245/s10434-017-5903-6 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer 1,5 2,5 3,5 3,5 Faina Nakhlis, MD , Meredith M. Regan, ScD , Laura E. Warren, MD , Jennifer R. Bellon, MD , 5 1,5 1,5 1,5 Judith Hirshfield-Bartek, RN , Margaret M. Duggan, MD , Laura S. Dominici, MD , Mehra Golshan, MD , 4,5 4,5 5 5 Heather A. Jacene, MD , Eren D. Yeh, MD , Erin E. Mullaney, RN , and Beth Overmoyer, MD 1 2 Department of Surgery, Brigham and Women’s Hospital, Boston, MA; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, Brigham and Women’s 4 5 Hospital, Boston, MA; Department of Radiology, Brigham and Women’s Hospital, Boston, MA; Inflammatory Breast Cancer Program of Dana-Farber Cancer Institute, Boston, MA ABSTRACT 0.07–0.41, p\ 0.0001, multivariate) and improved OS Background. Inflammatory breast cancer (IBC) is a rare (HR 0.26, 95% CI 0.11–0.65, p \ 0.01, univariate). In and aggressive disease treated with multimodality therapy: patients with pCR,

Journal

Annals of Surgical OncologySpringer Journals

Published: May 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off